The analyst will produce clear, defensible SCRM and national security risk assessments to inform HHS funding, mitigation, and risk-management decisions; support continuous vetting of selected awardees for material changes in risk; and collaborate with HHS program, grants, acquisition, research security, counterintelligence, Intelligence Community, law enforcement, and interagency partners to protect HHS-funded research, emerging technologies, intellectual property, supply chains, and national security equities. The analyst will conduct comprehensive due diligence and all-source analysis of companies, technologies, key personnel, investors, and research partners, examining foreign ownership, control and influence, corporate structures, beneficial ownership, investments, affiliations, research collaborations, intellectual property, patents and publications, technology transfer, supply-chain dependencies, and connections to foreign governments or entities of national security concern.